TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 15, No. 23 December 1, 2009
(The next issue will be on December 15, 2009)
__________________________________________________________
TRIGGER is also available by RSS Feed:
http://feeds.feedburner.com/blogspot/glro
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
UPCOMING MEETINGS & EVENTS
The XXXIII World Congress of the International Society of Hematology will take place in Jerusalem, Israel, October 10-13, 2010. For more information, go to:
http://www.kenes.com/ish2010
The 20th Congress of the International Society for Fibrinolysis and Proteolysis will be held in Amsterdam on August 24-28, 2010. For more information, go to:
http://www.isfp2010.org/
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1BwfadP5culEmKrmixp0KSI/
Beppu S, Nakajima Y, Shibasaki M, Kageyama K, Mizobe T, Shime N, and Matsuda N (2009) Phosphodiesterase 3 inhibition reduces platelet activation and monocyte tissue factor expression in knee arthroplasty patients. Anesthesiology 111:1227-1237.
http://www.ncbi.nlm.nih.gov/pubmed/19934866
Bilic E, Rajic L, Femenic R, Konja J, Vucic K, Novak M, Cvitkovic M, Galic S, and Krmek N (2009) Recombinant activated factor VII controls chemotherapy-related hemorrhage in patients with solid intra-abdominal tumors: A report of three pediatric cases. Acta Clin Croat 48:161-166.
http://www.ncbi.nlm.nih.gov/pubmed/19928415
Forest A, Pautas E, Ray P, Bonnet D, Verny M, Amabile N, Boulanger C, Riou B, Tedgui A, Mallat Z, and Boddaert J (2009) Circulating microparticles and procoagulant activity in elderly patients. J Gerontol A Biol Sci Med Sci
http://www.ncbi.nlm.nih.gov/pubmed/19942591
Fu Y, Zhang GG, Cao Y, Liu Y, Yu JF, and Yin XH (2009) [Effect of adenovirus-mediated tissue factor pathway inhibitor gene transfer on apoptosis of rat vascular smooth muscle cells]. Zhonghua Xin Xue Guan Bing Za Zhi 37:542-547.
http://www.ncbi.nlm.nih.gov/pubmed/19927638
Girardi G (2009) Role of tissue factor in the maternal immunological attack of the embryo in the antiphospholipid syndrome. Clin Rev Allergy Immunol
http://www.ncbi.nlm.nih.gov/pubmed/19921475
Gopalakrishnan R, Hedner U, Ghosh S, Nayak R, Allen TC, Pendurthi UR, and Rao LV (2009) Bio-distribution of pharmacologically administered rFVIIa. J Thromb Haemost
http://www.ncbi.nlm.nih.gov/pubmed/19943873
He X, Han B, Bai X, Zhang Y, Cypel M, Mura M, Keshavjee S, and Liu M (2009) PTX3 as a potential biomarker of acute lung injury: Supporting evidence from animal experimentation. Intensive Care Med
http://www.ncbi.nlm.nih.gov/pubmed/19921147
Iakhiaev MA and Iakhiaev AV (2009) Graph-theoretical comparison of protein surfaces reveals potential determinants of cross-reactivity and the molecular mimicry. Mol Immunol
http://www.ncbi.nlm.nih.gov/pubmed/19939450
Jing Y and Jian-Xiong Y (2009) Human tissue factor pathway inhibitor-2 suppresses the wound-healing activities of human Tenon's capsule fibroblasts in vitro. Mol Vis 15:2306-2312.
http://www.ncbi.nlm.nih.gov/pubmed/19936309
Leduc D, Senikas V, Lalonde AB, Ballerman C, Biringer A, et al. (2009) Active management of the third stage of labour: Prevention and treatment of postpartum hemorrhage. J Obstet Gynaecol Can 31:980-993.
http://www.ncbi.nlm.nih.gov/pubmed/19941729
Mackman N and Taubman M (2009) Tissue factor: Past, present, and future. Arterioscler Thromb Vasc Biol 29:1986-1988.
http://www.ncbi.nlm.nih.gov/pubmed/19923557
Mahnel R, Bassus S, and Kirchmaier CM (2009) [Bleeding complications due to anticoagulatoric therapy.]. Internist (Berl)
http://www.ncbi.nlm.nih.gov/pubmed/19924389
Ming XF, Rajapakse AG, Carvas JM, Ruffieux J, and Yang Z (2009) Opposing and uncoupling effects of mTOR and S6K1 in the regulation of endothelial tissue factor expression. FEBS Lett
http://www.ncbi.nlm.nih.gov/pubmed/19914247
Mobarrez F, Antovic J, Egberg N, Hansson M, Jorneskog G, Hultenby K, and Wallen H (2009) A multicolor flow cytometric assay for measurement of platelet-derived microparticles. Thromb Res
http://www.ncbi.nlm.nih.gov/pubmed/19939440
Nielsen VG, Kirklin JK, and George JF (2009) Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in hemophilia A, hemophilia B and factor VII-deficient plasmas. Blood Coagul Fibrinolysis
http://www.ncbi.nlm.nih.gov/pubmed/19923981
Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, and Cameron PA (2009) Recombinant activated factor VII in obstetric hemorrhage: Experiences from the Australian and New Zealand Haemostasis Registry. Anesth Analg 109:1908-1915.
http://www.ncbi.nlm.nih.gov/pubmed/19923520
Provencal M, Berger-Thibault N, Labbe D, Veitch R, Boivin D, Rivard GE, Gingras D, and Beliveau R (2009) Tissue factor mediates the HGF/Met-induced anti-apoptotic pathway in DAOY medulloblastoma cells. J Neurooncol
http://www.ncbi.nlm.nih.gov/pubmed/19921488
Takedani H, Kawahara H, and Kajiwara M (2009) Major orthopaedic surgeries for haemophilia with inhibitors using rFVIIa. Haemophilia
http://www.ncbi.nlm.nih.gov/pubmed/19925628
Tatopoulos A, Herbain D, Kazmierczak C, Bollaert PE, and Gibot S (2009) Parenteral use of recombinant activated factor VII during diffuse alveolar hemorrhage secondary to leptospirosis. Intensive Care Med
http://www.ncbi.nlm.nih.gov/pubmed/19924396
Wang HJ, Lo WY, Lu TL, and Huang H (2009) (-)-Epigallocatechin-3-gallate decreases thrombin/paclitaxel-induced endothelial tissue factor expression via the inhibition of c-Jun terminal NH2 kinase phosphorylation. Biochem Biophys Res Commun
http://www.ncbi.nlm.nih.gov/pubmed/19944065
____________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
